Another commonly mutated gene in pancreatic cancer is CDKN2A (> 40%), whose alterations are related mainly to cell cycle dysregulation, promoting its progression through the loss of cyclin-dependent kinase CDK4 and CDK6 inhibition [15]. This evidence concerns the gene CDKN2A and pancreatic neoplasm.